Veraxa Biotech Holding AG (VRXA) Enterprise Value (2024 - 2025)
Veraxa Biotech Holding AG's (VRXA) quarterly Enterprise Value came in at -$1.5 million in Q4 2025, up 75.91% year-on-year from -$862345.1 in Q4 2024, and up 75.91% on a QoQ basis from -$6.3 million in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Enterprise Value (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has 2 years of Enterprise Value data on file, last reported at -$1.5 million in Q4 2025.
- On a quarterly basis, Enterprise Value rose 75.91% year-over-year to -$1.5 million in Q4 2025; TTM through Dec 2025 was -$1.5 million, a 75.91% increase from a year earlier, with the FY2025 full-year figure at -$1.5 million, up 75.91% from the prior year.
- Enterprise Value for Q4 2025 stood at -$1.5 million, up from -$6.3 million in the prior quarter.
- Over the last five years, Enterprise Value for VRXA reached as high as -$1.5 million in Q4 2025 and fell as low as -$6.3 million in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.52 Mn |
| Dec 31, 2024 | -6.30 Mn |